The Investor You Choose Can Be More Important Than the Money You Raise

When a promoter raises capital, the discussion usually revolves around three questions: How much money do I need? At what valuation? How much dilution?

All three matter. But there is another question that is often overlooked: what kind of investor am I bringing onto my cap table?

An investor brings much more than money. They bring expectations, a time horizon, rights, influence, networks and, eventually, an expectation of an exit.

There is no wrong investor. There can be a wrong fit. An investor looking for an exit in three years is not necessarily wrong. A patient investor willing to stay for ten years is not necessarily right. The real question is: does the investor's investment thesis fit the promoter's business thesis?

Secondary-Market Thinking Applied to Early-Stage Capital

I have often seen investors accustomed to the secondary market invest in early-stage companies. These are fundamentally different investments.

In a listed company, an investor has years of financial history, an established business model, a management track record and a visible market for exit. An early-stage company is different. Much of the investment thesis is based on what the business can become, rather than what it has already demonstrated.

Yet investors sometimes bring the expectations of the secondary market into an early-stage investment: When will you become profitable? When will you list? When will I get my money back?

The investor is not necessarily wrong. The investment thesis may simply not match the business thesis.

Capital Should Fit the Journey

FOMO can make the mismatch worse. I have seen investors invest because others are investing, without adequately thinking through their own exit expectations. Later, they feel stuck and put pressure on the promoter for an IPO or a buyback.

The investor must exercise independent judgment about a reasonable exit timeline. But the promoter has an equal responsibility. If the business is still finding product-market fit, exploring markets or refining its business model, it may genuinely need patient capital.

The promoter should not chase short-term capital simply because it is available.

Don't Look Only at Valuation

Promoters negotiate valuation and dilution carefully, but sometimes pay less attention to the rights attached to the investment in the term sheet.

I have seen promoters sign term sheets under pressure and later discover restrictions that affect their ability to run the business. The term sheet deserves as much attention as the valuation.

Look at the Investor Beyond the Cheque

An investor's background matters too. Some investors become an asset to the company. Their credibility attracts other investors and talent; their networks open doors to customers, partners and future funding.

Others may bring a large cheque but little else, and their reputation may become a liability. The cap table is not merely an ownership document. It is also a signal to the market.

I have also seen investors who offer guidance when needed, open their networks, introduce customers and future investors, and support the promoter when things get difficult. They have not merely made an investment. They have become partners.

Lawrence Cunningham's "Quality Shareholders," with Warren Buffett's Berkshire Hathaway as an important example, makes a similar broader point: companies benefit from informed, committed and patient shareholders who think like owners and support long-term value creation rather than creating pressure every quarter.

One line captures the idea: "Managers get the shareholders they deserve."

Investor–Business Thesis Fit

For promoters, I would put it differently: choose your investors as carefully as you choose your capital.

Just as you need Product–Market Fit, you also need Investor–Business Thesis Fit. The cheque funds the journey. The investor becomes part of it.